Issue 6

Nonpharmaceutical Therapies for Dry Eye Disease
Milton M. Hom, OD, FAAO

Systemic Autoimmunity and Dry Eye Disease
Jillian Ziemanski, OD, MS, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Broaden use of nonpharamceutical modalities for DED treatment.

• Describe non-drop pipeline therapies that may become available in the near future.

• Suspect and diagnose autoimmune disease in patients with DED.

• Manage DED in patients with underlying systemic disorder.

Issue 5

Dry Eye Symptomatology and Pathophysiology: New Understandings
Kelly K. Nichols, OD, MPH, PhD, FAAO

Examination and Imaging for Dry Eye Disease Evaluation
Katherine M. Mastrota, MS, OD, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Use the patient-centric classification scheme to guide clinical decisions in the diagnosis and treatment of DED.

• Outline the core mechanisms and the vicious inflammatory circle that underlie the initiation and perpetuation of DED.

• Understand the role of the meibomian glands in ocular surface health and disease.

• Better assess meibomian structure and function in everyday practice.

Issue 4

Ocular Surface Disease in Glaucoma Patients
Leo Semes, OD

Dry Eye Disease in Ocular Surgery Patients
Walter O. Whitley, OD, MBA, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Identify underlying causes of OSD among ocular hypertension/glaucoma patients.

• Design a treatment plan to manage OSD in ocular hypertension/glaucoma patients.

• Identify issues specific to DED patients undergoing surgery.

• Better manage DED patients before and after surgery.

Issue 3

Algorithms as Management Tools in the Treatment of Dry Eye Disease
Douglas K. Devries, OD 

Contact Lens Wear and the Ocular Surface
Anna F. Ablamowicz, OD FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Explain the methodology and function of an algorithm for DED management.

• Describe the advantages and limitations of practice guidelines, and describe the ways to incorporate algorithms effectively into clinical practice.

• Counsel patients regarding interactions between contact lenses and the tear film and their implications.

• Identify and better manage dry eye in contact lens-wearing patients.

Issue 2

Inflammation in Dry Eye Disease
Blair Lonsberry, OD, FAAO

Communicating with Dry Eye Patients 
Whitney Hauser, OD

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Describe the pathophysiology of DED, including the role of inflammation and prevention.

• Implement basic DED diagnosis and management into daily practice.

• Know how to screen for DED in everyday practice.

• Improve compliance and outcomes by skillful communication with patients. 

Issue 1

Diagnostic Challenges in Ocular Surface Disease
Derek Cunningham, OD, FAAO

Allergic Conditions Affecting the Ocular Surface
Mile Brujic, OD, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Differentiate various forms of ocular surface disease, including dry eye disease, ocular allergy, and infectious conjunctivitis, based on patient history, clinical presentation, and diagnostic testing.

• Recognize comorbidities in patients with ocular surface disease and formulate the appropriate treatment strategy.

• Identify the most common causes of acute and chronic allergic conjunctivitis.

• Design an appropriate course of management for patients with acute allergic conjunctivitis.